Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial (aiRTo-PDR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02447185
Recruitment Status : Recruiting
First Posted : May 18, 2015
Last Update Posted : September 24, 2018
Sponsor:
Collaborator:
The First People's Hospital of Xuzhou
Information provided by (Responsible Party):
JUNYAN ZHANG, The First People's Hospital of Xuzhou

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2021
Publications of Results: